Dokumentumok
100% at the KRAS European External Quality Assessment Schemes 2010
As the only Hungarian diagnostic service provider KPS Molecular Diagnostics scored 100% at KRAS European External Quality Assessment Schemes 2010 organized by the European Society of Pathologists. Samples for the KRAS European external quality assessment scheme 2010 were dispatched in July 2010. Each participant received 3 unstained sections, paraffin-embedded material from 10 invasive colorectal carcinomas to be analysed for the presence of KRAS mutations. From 27 participating laboratories, 21 reported all 10 genotypes correctly. KPS scored 100% which is above the average European genotyping score 94%. Results of the KRAS European external quality assessment scheme 2010 were evaluated and discussed in the QAu ESP working group on 19/10/2010. This EQA Report is authorized by Prof Dr J Van Krieken and Prof Dr E Dequeker. More»
Further news
Our publication has been released in Nature Reviews Drug Discovery
In July, Nature Reviews Drug Discovery will publish our CEO's paper about the chances of development of novel drug compounds and targeted therapy in the future. In the 1990s, the breast cancer drug trastuzumab (Herceptin; Genentech/Roche) More»
The benefit of science TODAY
The emergence of molecular-targeted medicine at the turn of the 21st century brought a breakthrough in the personalized treatment of tumors and inflammations, comparable only to the discovery of penicillin. At the turn of the nineteenth More»
Clinical course of laryngo-respiratory symptoms in gastro-oesophageal reflux disease during routine
BACKGROUND: Gastro-oesophageal reflux disease (GERD) can be associated with laryngo-respiratory symptoms (LRS) such as chronic cough, asthma or laryngeal symptoms. AIM: To analyse the long-term clinical course of LRS in a large population More»
Exposure to Low-Dose Ionizing Radiation from Medical Imaging Procedures
Background: The growing use of imaging procedures in the United States has raised concerns about exposure to low-dose ionizing radiation in the general population. Methods: We identified 952,420 nonelderly adults (between 18 and 64 More»
